Digital Biomarkers Archives | Page 3 of 3

EMA Offers Clarity on Digital Biomarker Terminology and Submission Process

By Koneksa HealthArticle21 Comments

Earlier this month, the European Medicines Agency (EMA)’s Human Medicines Division issued “Questions and Answers: Qualification of Digital Technology-Based Methodologies to Support Approval of Medicinal Products.” The Q&A explains considerations...

June 17, 2020

Koneksa on Digital Medicine and Wearable Technologies

By Koneksa HealthArticle34 Comments

In early March, Koneksa’s Chief Scientific Officer, Elena Izmailova, Ph.D., presented at the pre-conference workshop “Digital Medicine 101” and shared the results of Koneksa work at the “Digital Tools Enabling…

March 23, 2020

An Update From the Cutting Edge – The FNIH Biomarker Consortium

By Koneksa HealthArticle34 Comments

Recently, Koneksa’s CEO Chris Benko and I had the opportunity to participate – and I had the opportunity to present – at a workshop on “Remote Digital Monitoring for Medical…

February 28, 2020

Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials

By Koneksa HealthNews

CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research,...

November 7, 2016

Digital Biomarkers

EMA Offers Clarity on Digital Biomarker Terminology and Submission Process

Koneksa on Digital Medicine and Wearable Technologies

An Update From the Cutting Edge – The FNIH Biomarker Consortium

Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa